Rockefeller Capital Management’s Coya Therapeutics COYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Hold
2,000
– – ﹤0.01% 4174
2026
Q2
$11.7K Hold
2,000
– – ﹤0.01% 3950
2026
Q1
$7.88K Buy
2,000
+500
+33% +$2.34K ﹤0.01% 4091
2025
Q4
$8.7K Buy
1,500
+1,000
+200% +$6.08K ﹤0.01% 3863
2025
Q3
$2.85K Buy
+500
New +$3.04K ﹤0.01% 4021

Other funds holding COYA

Rockefeller Capital Management's COYA Position: Q3 2026 in Review

Rockefeller Capital Management held its Coya Therapeutics (COYA) position steady in Q3 2026 at 2,000 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4174.

Rockefeller Capital Management first reported a position in COYA in Q3 2025 and has held it in 5 quarters since. The position peaked at $11.7K in Q2 2026. 52 funds tracked by Wall St. Rank hold COYA as of Q3 2026.

  • Rockefeller Capital Management held 2,000 shares of Coya Therapeutics worth $10K as of Q3 2026.
  • Rockefeller Capital Management left its Coya Therapeutics share count unchanged in Q3 2026.
  • Coya Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4174 holding.
  • Rockefeller Capital Management first reported a position in Coya Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Coya Therapeutics position peaked at $11.7K in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Coya Therapeutics as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.